MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence

Authors: Radhika Mathur, Yalan Zhang, Matthew R Grimmer, Chibo Hong, Michael Zhang, Saumya Bollam, Kevin Petrecca, Jennifer Clarke, Mitchel S Berger, Joanna J Phillips, Nancy Ann Oberheim-Bush, Annette M Molinaro, Susan M Chang, Joseph F Costello

Published: 2020-03-11

DOI: 10.1093/neuonc/noaa059

Source: Full article

MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence

Abstract